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Abstract 
Staphylococcus species are among the most common resistant bacteria associated with the 
major cause of human ailments. The crude methanol extract from Ocimum americanum (OA) 
leaves was tested alone or in combination with norfloxacin (NOR) against strains of 
Staphylococcus aureus using the broth microdilution assay. The cytotoxicity of the OA extract 
was also evaluated using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) reagent assay on a HepG2 hepatocarcinomal cell line. Whilst the plant extract 
exhibited a mild to poor antibacterial activity against our panel of bacteria, the antibiotic 
activity of norfloxacin at one-quarter MIC was enhanced by 2-4 fold in the presence of one-
half MIC of OA extract against SA-1199B that over expresses the NorA efflux pump and 
against MRSA-274829 with synergistic effect. These positive interactions were confirmed 
using a time-killing test; the combination therapy completely attenuated the bacterial count of 
SA1199B but yielded a 4.2-log10-CFU/mL decrease for MRSA274829 after 24h incubation. 
The OA extract strongly depleted DPPH* (IC50: 146.5μg/mL), LOI (152 µg/mL), PGI (47.6 
µg/mL) and FRAP (122.75 µmolFe(II)/g) which is partly explained by the FRAP activity due 
to its richness in phenolic compounds. Furthermore, the OA extract showed a non-toxic effect 
on the HepG2 cells having an IC50 value of 378.0 μg/mL. These findings therefore support the 
folkloric use of Ocimum americanum at least in part for the treatment of infectious and free 
radical stress-related diseases. 
Keywords: Ocimum americanum; polyphenols, HPLC fingerprint; cytotoxicity; MRSA; 
resistance modifier 
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1. Introduction  
 
The global distribution of multidrug methicillin-resistant staphylococci is increasingly limiting 
the effectiveness of current antibiotic therapeutic agents due to acquired resistance to drugs 
(Nascimento et al., 2000). Methicillin-resistant Staphylococcus aureus (MRSA) is one of the 
most problematic clinically-relevant pathogens due to its intrinsic virulence and ability to adapt 
to various environmental conditions (Waldvogel, 2000). It is a leading cause of nosocomial 
resistance despite the availability of effective antimicrobials (Luzzaro et al., 2002). The high 
prevalence of infectious diseases caused by MRSA bacterial strains has motivated the search 
for new antibacterial agents with the capacity to circumvent resistance mechanisms or to 
modulate the activity of older antimicrobials (Sibanda and Okoh, 2007). Medicinal plants 
remain a natural reservoir of biologically active metabolites with unique chemistry that may 
perhaps hold a solution to the development of new drugs and to alleviate many side effects 
often related with modern medicines. However, only a small number of these botanicals has 
been evaluated and received rigorous scientific evaluation to assess their efficacy. 
Ocimum americanum L (Lamiaceae) also known as Ocimum canum is generally distributed 
through India and tropical Africa (Khare, 2007). The leaves are tiny, elliptic lanceolate, faintly 
toothed and gland-dotted and are endowed with an aromatic essential oil. The plant is locally 
known as “Efinrin elewe dudu” in south-west region of Nigeria where its leaves is prepared as 
decoction or infusion for the management of piles, dysentery, fever, coughs, cold, skin diseases, 
diabetes, indigestion, diarrhoea, toothache, migraine and microbial infections (Ekundayo et al., 
1989). It is also used in the preparation of local soup local among the Yoruba tribe and local 
condiment possibly due to its aromaticity (Bassole et al., 2005). Recent studies show the 
hepatoprotective and antioxidative capacities of the ethyl acetate, n-butanol, hydroalcoholic 
and acetone extracts from the leaves of Ocimum americanum (Aluko et al., 2012; 2013; Oboh, 
2008). So far, the main chemical constituents isolated from OA leaf extracts include methyl 
cinnamate, methylheptenone, d-camphor, citral, ocimin, linalool, nevadensin, beta-sitosterol, 
betulinic, ursolic, oleanolic acids and pectolinarigenin-7-methyl ether (Ekundayo et al., 1989), 
which are mostly volatile. Berhow et al. (2012) identified rosmarinic acid and caffeic acid 
derivatives in the aqueous leaf extract of Ocimum americanum with diverse therapeutic 
potentials. The majority of the studies conducted on this botanical reported some biological 
activities of its essential oil but there is a paucity of scientific data existing on the antibacterial 
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activity of OA leaf extracts against strains with characterised efflux-mediated mechanisms of 
resistance. The present study, therefore reports the antibacterial, bacterial-resistance 
modulation and time kill studies of Ocimum americanum against a panel of Staphylococcus 
aureus strains as well as cytotoxicity and HPLC-DAD fingerprints of its phenolic compounds.  
2. Materials and Methods 
2.1. Plants collections and preparation 
The dried and powdered leaves of Ocimum americanum (OA) were obtained from a local 
farmland near Orin Ekiti South-Western Nigeria in May, 2011. It was identified and 
authenticated by Mr. Omotayo (herbarium curator) at the Department of Plant Science, 
University of Ado-Ekiti, Nigeria where the voucher specimen (OA-001) was deposited. Fifty 
grams of the dried powdered plant material was extracted in 1 L methanol on a mechanical 
shaker (Labotec Scientific Orbital Shaker, South Africa) for 48 h and the extract was filtered 
using a Buchner funnel and Whatman No.1 filter paper. The volume was concentrated under 
vacuum at 40°C to recover the solvent and stored in the refrigerator at 6oC for future use. The 
herbal preparation involved the boiling of a handful of broken leaves in approximately 1.5 L 
of water for 15 min, after which the decoction was strained and served. Methanol was chosen 
in this study to bridge the gap and as a good solvent for the extraction of phenolic compounds. 
2.2. Bacterial strains 
Staphylococcus aureus strains NCTC 12981 (methicillin-susceptible), NCTC-13373 
(methicillin-resistant), MRSA- 274829, EMRSA-15 and the susceptibility testing standard S. 
aureus isolate ATCC-25923 (methicillin-resistant) were obtained from Dr Paul Stapleton, UCL 
School of Pharmacy. SA-1199B, kindly provided by Dr G. W. Kaatz, is a multidrug-resistant 
S. aureus strain that overexpresses the NorA efflux pump. EMRSA-15 is a major epidemic 
methicillin-resistant S. aureus (MRSA) strain prevalent in UK Hospitals (Richardson and 
Reith, 1993) and is notable for the presence of mecA gene which contributes to the resistance 
phenotype. The inocula of the test organisms were prepared using the colony suspension 
method (Oluwatuyi et al., 2004) with adjustment utilising a 0.5 McFarland turbidity standard 
followed by dilution to achieve 5 × 105 colony forming units per mL (CFU/mL). 
2.3. Cells culture and Maintenance 
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The HepG2 cell lines (American Type Culture Collection) were obtained from Prof. Andreas 
Kortenkamp at the UCL School of Pharmacy. HepG2 cells were replenished with new growth 
medium every 2-3 days and sub-cultured when reaching 80% confluence. Cells were 
maintained in Dulbecco’s Modified Eagles Medium (DMEM) (Invitrogen, UK) containing 
10% fetal bovine serum (GIBCO 10010) and antibiotics [Penicillin (100 IU/mL) and 
streptomycin (100 µg/mL)] incubated at 37oC in a 5% CO2 humidified atmosphere. The cells 
were allowed to grow in the medium before harvesting for the MTT assays. The cell density 
was adjusted to 7.5 x 104 cells/mL before exposed to different concentrations of plant extracts 
prepared in 1 % v/v DMSO. The assays were performed in triplicate for each extract 
concentration while the mean values were calculated and compared with the controls. 
2.4. Ferric reducing antioxidant power (FRAP) 
The antioxidative capacity of the OA extracts to reduce ferric ions was measured using the 
method described by Benzie and Strain (1999). The FRAP reagent was prepared by mixing 20 
mL acetate buffer (300 mM sodium acetate, pH 3.6), 2 mL TPTZ (tripyridyl-s-triazine) 
solution, with 2 mL of FeCl3 solution and 2.4 mL of distilled water. The straw coloured solution 
was incubated in a water bath at 37oC for 10 min. 10 µL of the sample was transferred into a 
96 well plate and allowed to react with 250 µL of freshly prepared FRAP reagent in the dark. 
After 5 min, the absorbance was measured and recorded at 593 nm against a blank solution 
(distilled water instead of extract). Results were expressed as catechin equivalents (mg/g) using 
the equation from the calibration curve: Y = 0.3329x, R2 = 0.9763 where x was the absorbance 
and Y the catechin equivalent (mg/g). 
2.5. Free radical scavenging activity (FRSA) using the DPPH assay 
The DPPH radical scavenging properties of methanol crude extracts from OA leaves were 
evaluated according to the method of Yan et al. (1998) with slight modification. Twenty five 
milligrams of the crude extract (3.125-100 µg/mL) were dissolved in methanol and 1.5 mL of 
this solution was added to 1.5 mL of 0.1 mM DPPH dissolved in DMSO. The reaction mixture 
was vortexed thoroughly and left in the dark at room temperature for 30 min. The absorbance 
was read at 517 nm after 2 min. The FRSA was calculated as [Ao-A1/Ao ×100], where A1 was 
the absorbance of 1.5 mL of the crude extract solution mixed with an equal volume of the 
DPPH solution whereas Ao was the absorbance of DPPH mixed with an equal volume of 
DMSO. The experiment was carried out in triplicate to determine the mean values. Caffeic acid 
was used as a reference standard. 
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2.6 Inhibition of lipid oxidation (LOI) 
The inhibitory potential of methanol extracts from OA leaves against lipid peroxide formation 
was determined using a modified thiobarbituric acid-reactive species (TBARS) assay 
(Dharmananda, 2012). Egg homogenate (0.5 mL, 10% in distilled water, v/v) and 0.1 mL of 
the methanol leaves extracts from OA was mixed in a test tube and made up to 1 mL with 
distilled water. A volume of 0.05 mL FeSO4 (0.07 M) was added to the above mixture and 
further incubated for 30 min, to induce lipid oxidation. Thereafter, 1.5 mL of 20% acetic acid 
(pH 3.5), 1.5 mL of 0.8 % w/v TBA prepared in 1.1 % w/v sodium dodecyl sulphate  (SDS) 
and 0.5 mL of 20 % w/v TCA were added, vortexed and then heated in a boiling water bath for 
60 min.  To avoid non-MDA interference due to high anthocyanin formation, another set of 
samples were prepared in the same manner, incubated without TBA. After cooling, 5.0 mL of 
1-butanol was added to each tube and centrifuged at 3000 rpm for 10 min. The absorbance of 
the upper layer solution was measured at 532 nm. For the blank, 0.1 mL of distilled water was 
used instead of the extract. The percentage inhibition (% LOI) of peroxide formation by the 
plant extract was calculated using the equation (1-E/C) x 100, where C is the absorbance value 
of the fully oxidized control and E is change in absorbance of TBA present/absent. 
 
2.7 Inhibition of protein glycation 
Inhibition of albumin glycation by the OA extracts was done according to the method described 
by Matsuura et al. (2001). Six tubes were prepared for the blank and each of the extract 
concentrations (3, 6 and 12.5 μg/mL)  was mixed with 400 μL of 1 mg/mL BSA and 90 μL of 
1.11M glucose in 50 mM phosphate buffer (pH 7.4). Three of these samples were incubated in 
a 60°C water bath for 24 h with 10 μL of extracts or distilled water while another three tubes 
were kept at 4°C. After incubation, 100 μL of each sample was transferred to a new tube and 
10 μL of cold 100% TCA was added to each tube. They were vortexed and centrifuged at 15000 
× g for 4 min at 4°C. The pellet [containing advanced glycation end products (AGE)] was 
collected and dissolved in 400 μL of alkaline phosphate buffered solution (PBS). The 
fluorescence intensity was measured using a Multiscan MS microtitre plate reader with an 
excitation/emission wavelength of 370/440 nm. 
 
2.8. Minimum inhibitory concentration (MIC) assay 
The Minimum Inhibitory Concentration (MIC) of antibiotics and plant extract were determined 
against multidrug-resistant Staphylococcus aureus via the standard method of the Clinical 
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Laboratory Standards Institute (1994). S. aureus strains were cultured on nutrient agar (Oxoid) 
and incubated for 24 h at 37 °C prior to MIC determination. A volume of 100 μL of sterile 
Mueller-Hinton broth (MHB: Oxoid) containing 20 mg/L and 10 mg/L of Ca2+ and Mg2+ 
respectively was dispensed into 10 wells of a 96 well microtitre plate. The plant extract was 
dissolved in dimethyl sulfoxide (DMSO) and further diluted in MHB to give a stock solution. 
A volume of 100 μL of the antibacterial agent stock solution (2.048 mg/L) was serially diluted 
into each well and then mixed with 100 μL of standardized bacterial inocula to give a final 
concentration range from 512 to 1 mg/L. All procedures were performed in duplicate and the 
plates were incubated for 18 h at 37 °C. A volume of 20 μL of a 5 mg/mL methanol solution 
of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; Sigma) was added to 
each well and incubated for 30 min. A blue coloration indicated bacterial growth. The MIC 
was recorded as the lowest concentration at which no visible growth was observed. 
2.9. Antibacterial modulation assay 
The OA extract was evaluated as an antibiotic resistance modulator or modifier against 
Staphylococcus aureus resistant bacteria strains SA-1199B, NCTC 13373, NCTC 12981 and 
MRSA- 274829 in the presence or absence of norfloxacin or reserpine. Antibiotics or plant 
extracts were prepared in Mueller Hinton Broth (MHB) for synergistic combination with 
norfloxacin. Reserpine (20 µg/mL) a standard antibiotic modulator was used as the positive 
control. 100µL of norfloxacin or plant extract or reserpine was serially diluted across the plate, 
followed by adding 100 µL of each bacterial inoculum and then incubated at 37oC for 18 h. A 
volume of 20 µL MTT (5mg/mL) was added to the overnight cultures to detect bacterial growth 
by a colour change from yellow to blue. The MIC was determined as the lowest concentration 
at which no growth was observed.  
2.10.  Time kill-kinetics of the extract-antibiotic combination 
The combinatorial effects of methanol extracts and antibiotics against SA-1199B and MRSA 
274829 using the time kill assay as a method of investigation was used with slight modification 
(NCCLS, 1999). For time-kill assays, bacteria were freshly sub-cultured in MHB until the 
exponential phase was reached, diluted to approximately 5 × 105 CFU/mL in MHB containing 
antimicrobial agents (extract and antibiotics) and incubated for 24 h at 37oC with aliquots were 
taken from controls and the test samples at regular time intervals. To prevent drug carryover 
during serial dilution plating, aliquots were transferred to a recovery medium containing 3% 
Tween 80 and later plated on to nutrient agar in duplicate. The plates were incubated at 37oC 
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for 24 h under aerobic conditions. The number of surviving organisms in the presence of the 
combination was counted and the mean counts (CFU/mL) for each treatment were expressed 
as a logarithmic reduction. Bacteriostatic and bactericidal activities were defined as < 3-log10 
reductions and ≥ 3-log10 reductions in CFU/mL after 24 h of incubation, respectively, relative 
to the starting inocula. 
2.11. MTT toxicity assay 
The cytotoxicity of the herbal extract was determined using the MTT assay on human liver 
carcinoma cells as described by Mossman (1983). Briefly, HepG2 cells were seeded in 96-well 
plates with 1 x 104 cells in 0.1 mL of DMEM medium supplemented with 10% FBS and 
routinely cultured in a humidified incubator (37°C in 5% CO2) for 24 h to reach full confluence. 
100μL from each extract concentration were added, serially diluted (15.625-500 μg/mL) and 
then incubated for 24 h. After incubation, the medium was discarded and further incubated 
with 100 μL of tetrazolium dye (MTT) in 1 mg/mL PBS solution. The resulting dark blue 
formazan crystals formed due to mitochondrial activity after incubation was dissolved by 
adding 100 μL of DMSO into each well. The plate was then read on a microplate reader at 490 
nm. MTT solution with DMSO (without cells and medium) acted as a blank control in the 
microplate reading whilst the PBS-treated cells served as a control of 100% viability. 
2.12. HPLC/DAD analysis for phenolic compounds 
The phenolic compounds in the leaf methanol extracts from OA were identified and 
characterized by HPLC-DAD according to the method described by Giner et al. (1993). All 
analyses were performed using a Hewlett-Packard Chemstation series 1100 chromatograph 
(Agilent, Palo Alto, CA, USA), coupled with a diode array detector. Ten milligrams of the 
plant samples were sonicated in HPLC grade methanol (1 mL) for 30 min. The resultant 
mixtures were centrifuged at 10000 g for 10 min and the supernatants were used for the 
HPLC/DAD analysis. The resulting solutions were filtered through a 0.22 μm filter and 10 μL 
aliquots of the filtrates were injected onto the HPLC system. This system comprised a RP Nova 
Pack C18 column (300 x 3.9 mm) packed with 4 μm particles and a pre-column containing the 
same packing material. The columns were eluted in two solvent systems; Solvent A 
(water/phosphoric acid, 0.1%) and solvent B (methanol). The solvent gradient was composed 
of A (75-0%) and B (25-100%) for 20 min, then 100% B for 4 min, then again at the initial 
conditions (75% A and 25% B) for 10 min. A flow rate of 1.0 mL/min was used at 30oC. The 
UV spectral data for all peaks of different compounds were accumulated in 285 nm and 
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recorded using DAD. These compounds were identified by comparison of their retention times 
and spectra of each peak with those of known standards analysed in the same conditions. 
 
2.13. Statistics 
Data analysis was done on Microsoft Excel to obtain descriptive statistics. Mean values were 
separated by the Duncan multiple test using SAS. The different levels of significance within 
the separated groups were analyzed using one way analysis of variance (ANOVA). Values 
were considered significant at P<0.05. 
3.  Results and discussion 
Humans are constantly exposed to free radicals (FRs) such as hydroxyl (OH.), superoxide (O2
-
.) and nitric monoxide (NO.) via cosmic radiation, cellular metabolism and pollutants including 
cigarette smoke (Fridovich, 1999). These radicals are also generated in the human body as by 
products through diverse physiological and biochemical processes. However, the accumulation 
of FRs has been implicated in most studies as a major cause of oxidative damage to 
biomolecules such as lipids, proteins and DNA, which can subsequently lead to 
neurodegenerative diseases (Gilgun-sherki et al., 2001; Oyedemi and Afolayan, 2011). 
Epidemiological studies have shown that most diseases caused by these FRs can be ameliorated 
upon intake of natural antioxidants (Zandi et al., 2004). In this work, the antioxidative capacity 
of the methanol extract from Ocimum americanum leaves was assessed via its ability to reduce 
ferric 2, 4, 6-tripyridyl-s-triazine [TPRZ-Fe (III)] complex to the coloured ferrous form [TPTZ-
Fe (II)]. The OA extract exhibited a strong antioxidative potential, with an IC50 value of 122.75 
µmol Fe (II)/g higher than the standard BHT (75µmol Fe (II)/g) but significantly lower as 
compared to catechin (859.32 µmol Fe (II)/g (Table 1). In the same manner, a strong free 
radical scavenging activity (FRSA) was recorded having an IC50 value of 146.5 μg/mL, though 
markedly lower as compared to the standard caffeic acid (13.22 μg/mL). Due to the high 
phenolic components, it is possible that the extract donated electron or protons through the 
termination or suppression of free radical chain reactions (Fecka and Turek, 2008) into stable 
non-radical products which corresponds to the findings of Zhang et al. (2010) on some Ocimum 
species. 
Lipid oxidation (LO) is well-recognised as the major outcomes of free radical-mediated 
process, in which oxidative damage is propagated to polyunsaturated fatty acids via lipid-
derived radicals (alkoxyl and peroxyl). The oxidation of lipids alters the physicochemical 
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properties of membranes, resulting into severe cellular dysfunction such as cataract, 
rheumatoid arthritis and neurodegenerative disorders (Dharmananda et al., 2012). The 
inhibitory potential of the OA extracts and the standard drugs against TBARS production in 
the egg yolk homogenate induced by FeSO4 is presented in Table 1. The results are 
concentration dependent having IC50 values of 0.36, 0.06 and 0.102 mg/mL for the OA, BHT 
and gallic acid, respectively. The OA extract exhibited a strong antioxidative capacity to 
prevent MDA formation possibly due to its richness in phenolic compounds via different 
mechanisms such as chain breaking or termination (Hatano et al., 1989). Additionally, a 
possible synergistic interaction between the molecular compositions could also influence the 
observed LOI activity. Although, the LOI activity of OA extract is considered lower as 
compared to the standard BHT or gallic acid, however, being a natural product it could help 
protecting human cells against oxidative damage without causing adverse reaction. This could 
also justify its traditional use for the treatment of oxidative stress related diseases in the region. 
 
Reactive oxygen species (ROS) has been implicated in several human diseases through 
biomolecules damage and as a result alter cellular metabolism. The non-enzymatic interaction 
of ketone or aldehyde groups of reducing sugar with the free amino groups of proteins, lipids 
and nucleic acids resulting to the formation of advanced glycation end products (AGE). The 
generation of ROS during glycation diminishes oxidative defence system of protein via thiol 
groups reduction which has been implicated in the pathogenesis of diabetic micro and macro-
vascular complications (Kiho et al., 2000). Here, the plant extract suppressed the intensity of 
the fluorescent conjugated BSA (advanced glycation products) in a concentration dependent 
manner, indicating its antioxidative potential. The percentage protein glycation in the medium 
was reduced to 72.8, 65.7, 58.8, 53.2 and 48% at 3, 6, 12.5, 25 and 50μg/mL, respectively for 
OA extract while that of aminoguanidine at 0.12 μg/mL, a known inhibitor of protein glycation 
process, was reduced to 12.5% (Table 1). The PGI activity demonstrated by the OA extract 
was expressed as the IC50 (47.6 µg/mL), an effective concentration at which the glycation was 
inhibited by 50%, interpolated from the linear regression analysis. The result demonstrated that 
OA extract has anti-glycation properties at a concentration (47.6μg/mL) which is considered 
physiologically relevant and thus partially support its folkloric use in the treatment of diabetes.  
 
Numerous research studies have demonstrated the biological activities of Ocimum species and 
their essential oils (Nakamura et al., 1999). However, the antibacterial activity of this botanical 
against our panel of bacteria is reported here for the first time. The results of anti-MRSA 
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susceptibility tests of OA extracts and norfloxacin (NOR) using the broth microdilution method 
are presented in Table 2. In this work, we considered the anti-MRSA activity of the extract 
significant (MIC<100 mg/L), moderate (100<MIC=512 mg/L) or weak (MIC>512 mg/L) 
against six MRSA strains based on the classification of Rios and Recio (2005). The MICs of 
the OA extract showed varied antibacterial activity between the range of 256 and ≥ 512 mg/L 
and norfloxacin between 0.5 and 64 mg/L. The plant extract exhibited a moderate activity 
towards MRSA-274869, ATCC-25923 and SA-1199B, having MIC values ranging from 256 
to 512 mg/L but was inactive against NCTC-12981, NCTC-13373 and EMRSA-15 with MIC 
values > 512 mg/L. It is interesting to note that the OA extract inhibited the growth of SA-
1199B that overexpresses the NorA efflux pump conferring a high level of resistance to certain 
fluoroquinolone. In this bacterium, where the mechanism of resistance has been confirmed to 
be the NorA efflux protein (Oluwatuyi et al., 2004; Gibbons, 2005) this suggests that the OA 
extract may contain an active principle that is not a substrate for the NorA efflux protein.  
The use of combinatorial therapy has been suggested as a new approach to improve the efficacy 
of antimicrobial agents where monotherapy seems ineffective against drug resistant pathogens. 
Norfloxacin is a broad-spectrum antibacterial agent, commonly used for the treatment of a 
number of infectious diseases in clinical and veterinary medicine (Bjornsson et al., 2013; 
Beberok et al., 2015). In the recent times, the bacterial resistance to this agent has become an 
issue in antibiotic therapy. In this work, OA extract was tested for modulatory effect in the 
presence of norfloxacin towards NCTC-13373, SA-1199B, MRSA-274829 and NCTC-12981. 
The combination of the extract at one-half MIC with one-quarter MIC of norfloxacin showed 
no effect on the growth of NCTC-13373 and NCTC-12981 but displayed a reduction in the 
MIC of norfloxacin needed to attenuate the growth of MRSA-274829 and SA-1199B, 
respectively despite its weak antibacterial activity shown when tested alone. These results 
compared favourably well with reserpine a standard MDR inhibitor where the synergy 
interaction towards SA-1199B and MRSA-274829 is moderate. The observed activity 
indicated that OA extract could serve as a source of potential adjuvant of antibiotic or 
modulation of bacterial resistance mechanism (Oluwatuyi et al., 2004) considering the rich 
phytochemical constituents in the plant extract.  
The synergistic interaction arising from the combination of the OA extract and norfloxacin was 
further explored by using a time kill assay against SA1199B and MRSA274829. This method 
provides qualitative information on the pharmacodynamics of antimicrobial agents (Basri et 
al., 2014). The results of the time-kill experiments are given in Fig 1 and 2. The data showed 
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that OA alone at one-half MIC induce cell death while norfloxacin at one-quarter MIC reduced 
the bacterial counts of SA-1199B and MRSA-274829 strains to 2.5 and 3.1 log10 CFU/mL 
respectively, as compared to the initial inoculum of 6 log10 CFU/mL after a 24h incubation 
period. However, the bacteriostatic activity of norfloxacin was enhanced upon the addition of 
the OA extract dramatically and increased its killing rate as compared to antibiotic alone. At 
24 h of incubation, the bacterial growth of SA-1199B was completely attenuated to zero while 
MRSA-274829 was reduced to 1.8 log10 CFU/mL. This study provides a good concordance 
between the antibiotic potentiation activity and time-kill kinetics for the tested S. aureus strains. 
We found that the OA extract may perhaps have the potential to improve the effectiveness of 
norfloxacin activity by significantly reducing the growth of the effluxing bacteria SA-1199B 
and MRSA-274829. This result therefore confirms at least in part the use of OA extract in the 
treatment of microbial infections. Further studies are required to identify and characterized 
bioactive compounds responsible for the bacterial resistance modulation as well as probable 
mechanism of action. 
High performance liquid chromatography coupled with diode-array detection (HPLC-DAD) is 
an indispensable tool for phenolic compound analysis due to its versatility, precision and 
relatively low cost (Zhao et al., 2008). Little or no scientific information is available for the 
polyphenolic composition of OA leaf extract. In this study, the chromatogram at 285 nm 
showed the presence of 32 peaks of phenolic compounds with retention times (RT) between 3 
and 60 min. Here, none of the peaks identified based on their RT and UV/DAD absorption 
spectra corresponded with those of the standards (rutin, gallic acid, and quercetin) as shown in 
Fig 3. The HPLC fingerprints showed major peaks at the RTs (min) of 5.8, 10.2, 21.0, 24.7, 
26.6 and 40.2. Zarlaha et al. (2014) identified rosmarinic acid (4.9 min) and caffeic acid (4.1 
min) in Ocimum basilicum essential oil, a similar chemotype of Ocimum americanum, using 
HPLC coupled with DAD but these peaks are missing in this work, conceivably due to the 
difference in methodology and solvent system used. Nonetheless, the methanol crude extract 
from the OA leaves is rich in phenolic compounds and may justify the alcoholic decoction 
often employed during folkloric use for the treatment of diseases associated with oxidative 
stress. Further studies would be carried out to identify the major peaks of these compounds. 
MTT is a rapid and high accuracy colorimetric approach currently in use to determine the 
cytotoxic nature of plant-derived products for new drug discovery (Mossman, 1983). The assay 
measured the integrity of the cell membrane via the enzymatic reduction of MTT to a blue 
formazan product. The number of surviving cells is directly proportional to the level of the 
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formazan product quantified using a simple colorimetric assay. Currently, there is a dearth of 
data on the toxicity of Ocimum spp. Nonetheless, O. basilicum, the most exploited species due 
to its robust therapeutic value and culinary uses has been reported to be somewhat toxic to 
certain tumour cells; HeLa (cervical cancer cells): 164.61±2.58 µg/mL; Femx (Human 
melanoma cells): 191.36±2.42 µg/mL; K502 (Erythroleukeamia cells): 157±2.25µg/mL and 
SKOV3 (Ovarian carcinoma cells: >200 µg/mL) (Zarlaha et al., 2014). The plant extract 
exhibited a weak cytotoxic effect on HepG2 hepatocarcinomal cells, having an IC50 value of 
378 μg/mL, (Fig 4) which is significantly different as compared with the standard doxorubicin 
(0.5 µg/mL). This data therefore suggest that the OA extract did not impair mitochondrial 
viability and thus substantiates its ‘safe’ use as a complementary and alternative therapy for 
the treatment or prevention of diseases.  
4. Conclusion 
We have showed that Ocimum americanum had a strong antioxidative capacity which is 
evident from the data obtained from DPPH radical scavenging and ferric reducing antioxidant 
power due to its richness in phenolic compounds. The extract exhibited a synergistic interaction 
with norfloxacin in consonance with the time-kill kinetic data. Moreover, the OA extract was 
non-toxic towards human liver cells and hence, has some potential in the future design of safe 
combination anti-infective therapies against multidrug-resistant strains. Further studies are 
being carried out to isolate, characterize and understand the underlying mechanism of the 
extract-norfloxacin interaction. 
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